NEW YORK, March 29, 2019 (GLOBE NEWSWIRE) -- In
new independent research reports released early this morning,
Market Source Research released its latest key findings for all
current investors, traders, and shareholders of American Water
Works Company, Inc. (AWK), TripAdvisor, Inc.
(TRIP), ACADIA Pharmaceuticals Inc.
(ACAD), Dril-Quip, Inc. (DRQ), Domtar Corporation (UFS), and Cara Therapeutics, Inc. (CARA), including updated fundamental summaries,
consolidated fiscal reporting, and fully-qualified certified
analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
AWK DOWNLOAD: http://MarketSourceResearch.com/register/?so=AWK
TRIP DOWNLOAD: http://MarketSourceResearch.com/register/?so=TRIP
ACAD DOWNLOAD: http://MarketSourceResearch.com/register/?so=ACAD
DRQ DOWNLOAD: http://MarketSourceResearch.com/register/?so=DRQ
UFS DOWNLOAD: http://MarketSourceResearch.com/register/?so=UFS
CARA DOWNLOAD: http://MarketSourceResearch.com/register/?so=CARA
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Market Source Research, available for free download at the links above, examine American Water Works Company, Inc. (AWK), TripAdvisor, Inc. (TRIP), ACADIA Pharmaceuticals Inc. (ACAD), Dril-Quip, Inc. (DRQ), Domtar Corporation (UFS), and Cara Therapeutics, Inc. (CARA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 27th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
AMERICAN WATER WORKS COMPANY, INC. (AWK) REPORT OVERVIEW
American Water Works' Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, American Water Works reported revenue of $850.00MM vs $821.00MM (up 3.53%) and analysts estimated basic earnings per share $0.62 vs -$0.01. For the twelve months ended December 31st, 2018 vs December 31st, 2017, American Water Works reported revenue of $3,440.00MM vs $3,357.00MM (up 2.47%) and analysts estimated basic earnings per share $3.16 vs $2.39 (up 32.22%). Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.59. The estimated EPS forecast for the next fiscal year is $3.88 and is expected to report on February 18th, 2020.
To read the full American Water Works Company, Inc. (AWK) report, download it here: http://MarketSourceResearch.com/register/?so=AWK
-----------------------------------------
TRIPADVISOR, INC. (TRIP) REPORT OVERVIEW
TripAdvisor's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, TripAdvisor reported revenue of $346.00MM vs $321.00MM (up 7.79%) and analysts estimated basic earnings per share $0.05 vs -$0.60. For the twelve months ended December 31st, 2018 vs December 31st, 2017, TripAdvisor reported revenue of $1,615.00MM vs $1,556.00MM (up 3.79%) and analysts estimated basic earnings per share $0.82 vs -$0.14. Analysts expect earnings to be released on May 14th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.09. The estimated EPS forecast for the next fiscal year is $1.50 and is expected to report on February 11th, 2020.
To read the full TripAdvisor, Inc. (TRIP) report, download it here: http://MarketSourceResearch.com/register/?so=TRIP
-----------------------------------------
ACADIA PHARMACEUTICALS INC. (ACAD) REPORT OVERVIEW
ACADIA Pharmaceuticals' Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, ACADIA Pharmaceuticals reported revenue of $59.57MM vs $43.56MM (up 36.75%) and analysts estimated basic earnings per share -$0.49 vs -$0.56. For the twelve months ended December 31st, 2018 vs December 31st, 2017, ACADIA Pharmaceuticals reported revenue of $223.81MM vs $124.90MM (up 79.19%) and analysts estimated basic earnings per share -$1.94 vs -$2.36. Analysts expect earnings to be released on May 3rd, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.44. The estimated EPS forecast for the next fiscal year is -$0.90 and is expected to report on February 25th, 2020.
To read the full ACADIA Pharmaceuticals Inc. (ACAD) report, download it here: http://MarketSourceResearch.com/register/?so=ACAD
-----------------------------------------
DRIL-QUIP, INC. (DRQ) REPORT OVERVIEW
Dril-Quip's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Dril-Quip reported revenue of $97.34MM vs $107.97MM (down 9.85%) and basic earnings per share -$2.02 vs -$1.91. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Dril-Quip reported revenue of $384.63MM vs $455.47MM (down 15.55%) and analysts estimated basic earnings per share -$2.58 vs -$2.69. Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.24. The estimated EPS forecast for the next fiscal year is $0.81 and is expected to report on February 25th, 2020.
To read the full Dril-Quip, Inc. (DRQ) report, download it here: http://MarketSourceResearch.com/register/?so=DRQ
-----------------------------------------
DOMTAR CORPORATION (UFS) REPORT OVERVIEW
Domtar's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Domtar reported revenue of $1,390.00MM vs $1,335.00MM (up 4.12%) and analysts estimated basic earnings per share $1.39 vs -$6.16. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Domtar reported revenue of $5,455.00MM vs $5,148.00MM (up 5.96%) and analysts estimated basic earnings per share $4.50 vs -$4.11. Analysts expect earnings to be released on May 7th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.88. The estimated EPS forecast for the next fiscal year is $5.56 and is expected to report on February 4th, 2020.
To read the full Domtar Corporation (UFS) report, download it here: http://MarketSourceResearch.com/register/?so=UFS
-----------------------------------------
CARA THERAPEUTICS, INC. (CARA) REPORT OVERVIEW
Cara Therapeutics' Recent Financial Performance
For the twelve months ended December 31st, 2018 vs December 31st, 2017, Cara Therapeutics reported revenue of $13.47MM vs $0.91MM (up 1,378.49%) and analysts estimated basic earnings per share -$2.06 vs -$1.86. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.51. The estimated EPS forecast for the next fiscal year is -$2.31 and is expected to report on March 10th, 2020.
To read the full Cara Therapeutics, Inc. (CARA) report, download it here: http://MarketSourceResearch.com/register/?so=CARA
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members.